iRadimed Corporation (IRMD) Financial Statements (2026 and earlier)

Company Profile

Business Address	12705 INGENUITY DRIVE ORLANDO, FL 32826
State of Incorp.	DE
Fiscal Year End	December 31
Industry (SIC)	3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info	Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

	3/31/2026 MRQ	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments		51,159	52,234	49,762	57,961	62,501	51,978
Cash and cash equivalent		51,159	52,234	49,762	57,961	62,000	50,069
Short-term investments						502	1,909
Receivables		13,667	10,557	12,224	13,275	5,137	4,575
Inventory, net of allowances, customer advances and progress billings		11,620	10,402	12,821	5,369	4,300	3,934
Inventory		11,620	10,402	12,821	5,369	4,300	3,934
Prepaid expense					254	3,306	2,477
Other undisclosed current assets		4,757	2,050	1,193	631	1,001	772
Total current assets:		81,203	75,242	76,001	77,490	76,245	63,736
Noncurrent Assets
Operating lease, right-of-use asset			155	2,043	2,205	2,482	2,715
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization		23,856	16,811	9,289	2,400	2,069	2,120
Intangible asset, including goodwill, after accumulated amortization		3,384	3,099	2,519	2,069	1,119	961
Intangible asset, excluding goodwill, after accumulated amortization		3,384	3,099	2,519	2,069	1,119	961
Deferred income tax assets		94	2,820	2,123	701	765	1,273
Other noncurrent assets		239	199	181	649	201	262
Total noncurrent assets:		27,573	23,084	16,155	8,024	6,636	7,331
TOTAL ASSETS:		108,776	98,326	92,156	85,514	82,881	71,067
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities		6,996	5,949	13,079	4,887	3,847	2,566
Taxes payable	✕	✕	✕	✕	✕	140	104
Employee-related liabilities	✕	✕	✕	✕	✕	2,815	1,715
Accounts payable		1,820	1,896	1,857	1,799	783	657
Accrued liabilities		5,176	4,053	11,222	3,088	109	90
Deferred revenue		2,871	2,260	2,570	3,373	2,553	1,949
Other liabilities		313	150	250		146	146
Other undisclosed current liabilities			153	428	293	277	256
Total current liabilities:		10,180	8,512	16,327	8,554	6,823	4,917
Noncurrent Liabilities
Long-term debt and lease obligation:						2,206	2,459
Liabilities, other than long-term debt		3,978	2,995	4,409	3,287	1,679	2,305
Deferred revenue		3,978	2,993	2,794	1,375	1,679	2,305
Operating lease, liability			1	1,615	1,912	2,206	2,459
Total noncurrent liabilities:		3,978	2,995	4,409	3,287	3,885	4,765
Total liabilities:		14,158	11,507	20,736	11,841	10,708	9,682
Equity
Equity, attributable to parent		94,618	86,819	71,420	73,673	72,174	61,385
Common stock		1	1	1	1	1	1
Additional paid in capital		30,386	30,027	28,161	26,407	25,161	23,677
Accumulated other comprehensive income						17	37
Retained earnings		64,231	56,791	43,258	47,264	46,995	37,669
Total equity:		94,618	86,819	71,420	73,673	72,174	61,385
TOTAL LIABILITIES AND EQUITY:		108,776	98,326	92,156	85,514	82,881	71,067

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

	3/31/2026 TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenues		83,814	73,242	65,562	53,303	41,815	31,717
Cost of revenue		(19,490)	(16,892)	(15,404)	(12,021)	(9,765)	(8,143)
Gross profit:		64,324	56,350	50,158	41,282	32,050	23,574
Operating expenses		(38,177)	(34,385)	(30,123)	(25,655)	(22,232)	(24,331)
Operating income (loss):		26,147	21,965	20,035	15,628	9,818	(756)
Nonoperating income		2,214	2,311	1,703	553	19	139
Investment income, nonoperating		2,009	2,193	1,864	590	53	149
Gain (loss), foreign currency transaction, before tax		2	(43)	(149)	(37)	(35)	(10)
Income (loss) from continuing operations before income taxes:		28,361	24,275	21,738	16,181	9,836	(617)
Income tax expense (benefit)		(5,881)	(5,041)	(4,545)	(3,352)	(511)	1,986
Income from continuing operations:		22,480	19,234	17,193	12,828	9,325	1,369
Income before gain (loss) on sale of properties:	✕	✕	✕	✕	✕	9,325	1,369
Net income available to common stockholders, diluted:		22,480	19,234	17,193	12,828	9,325	1,369

Comprehensive Income ($ in thousands)
Annual | Quarterly

	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Net income:	22,480	19,234	17,193	12,828	9,325	1,369
Other comprehensive income (loss)				(17)	(20)	7
Comprehensive income, net of tax, attributable to parent:	22,480	19,234	17,193	12,811	9,305	1,376

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Financial Reporting
and Analysis Software

iRadimed Corporation (IRMD) Financial Statements (2026 and earlier)

Company Profile

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

Comprehensive Income ($ in thousands)
Annual | Quarterly

Statements Sources

Login to ReadyRatios

Financial Reportingand Analysis Software

iRadimed Corporation (IRMD) Financial Statements (2026 and earlier)

Company Profile

Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly

Income Statement (P&L) ($ in thousands)Annual | Quarterly

Comprehensive Income ($ in thousands)Annual | Quarterly

Statements Sources

Login to ReadyRatios

Financial Reporting
and Analysis Software

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

Comprehensive Income ($ in thousands)
Annual | Quarterly